JP2025090723A5 - - Google Patents

Info

Publication number
JP2025090723A5
JP2025090723A5 JP2025038216A JP2025038216A JP2025090723A5 JP 2025090723 A5 JP2025090723 A5 JP 2025090723A5 JP 2025038216 A JP2025038216 A JP 2025038216A JP 2025038216 A JP2025038216 A JP 2025038216A JP 2025090723 A5 JP2025090723 A5 JP 2025090723A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cancer
lipid
peg
sting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025038216A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025090723A (ja
Filing date
Publication date
Priority claimed from JP2022521307A external-priority patent/JP7650873B2/ja
Application filed filed Critical
Publication of JP2025090723A publication Critical patent/JP2025090723A/ja
Publication of JP2025090723A5 publication Critical patent/JP2025090723A5/ja
Pending legal-status Critical Current

Links

JP2025038216A 2019-10-09 2025-03-11 メッセンジャーrnaの組成物、方法および使用 Pending JP2025090723A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962913035P 2019-10-09 2019-10-09
US62/913,035 2019-10-09
JP2022521307A JP7650873B2 (ja) 2019-10-09 2020-10-09 メッセンジャーrnaの組成物、方法および使用
PCT/US2020/054952 WO2021072172A1 (en) 2019-10-09 2020-10-09 Compositions, methods and uses of messenger rna

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022521307A Division JP7650873B2 (ja) 2019-10-09 2020-10-09 メッセンジャーrnaの組成物、方法および使用

Publications (2)

Publication Number Publication Date
JP2025090723A JP2025090723A (ja) 2025-06-17
JP2025090723A5 true JP2025090723A5 (cg-RX-API-DMAC7.html) 2025-09-08

Family

ID=73040270

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022521307A Active JP7650873B2 (ja) 2019-10-09 2020-10-09 メッセンジャーrnaの組成物、方法および使用
JP2025038216A Pending JP2025090723A (ja) 2019-10-09 2025-03-11 メッセンジャーrnaの組成物、方法および使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022521307A Active JP7650873B2 (ja) 2019-10-09 2020-10-09 メッセンジャーrnaの組成物、方法および使用

Country Status (6)

Country Link
US (2) US12076438B2 (cg-RX-API-DMAC7.html)
EP (2) EP4529928A3 (cg-RX-API-DMAC7.html)
JP (2) JP7650873B2 (cg-RX-API-DMAC7.html)
CN (1) CN114728176B (cg-RX-API-DMAC7.html)
ES (1) ES3028783T3 (cg-RX-API-DMAC7.html)
WO (1) WO2021072172A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023004299A (es) * 2020-10-13 2023-07-07 Univ Pennsylvania Direccionamiento de células t cd4+ in vivo para terapeuticos de arnm.
CN115960906A (zh) * 2022-05-07 2023-04-14 苏州科锐迈德生物医药科技有限公司 用于抗肿瘤免疫治疗的rna组合物、rna制剂及用途
WO2024164006A2 (en) * 2023-02-03 2024-08-08 The Regents Of The University Of California Self-amplifying rna form of a constitutively-active sting protein for enhancing t-cell response to antigenpresenting cells
WO2024240962A1 (en) * 2023-05-25 2024-11-28 Ethris Gmbh Gm-csf-encoding nucleic acids, pharmaceutical compositions, methods and uses thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
FR2645866B1 (fr) 1989-04-17 1991-07-05 Centre Nat Rech Scient Nouvelles lipopolyamines, leur preparation et leur emploi
US5334761A (en) 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
CA2569664C (en) 2004-06-07 2013-07-16 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
PL2578685T3 (pl) 2005-08-23 2020-01-31 The Trustees Of The University Of Pennsylvania Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania
AU2009303345B2 (en) 2008-10-09 2015-08-20 Arbutus Biopharma Corporation Improved amino lipids and methods for the delivery of nucleic acids
WO2010053572A2 (en) 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
EA022786B1 (ru) 2009-07-31 2016-03-31 Этрис Гмбх Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков
US8326547B2 (en) 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
SI2506857T1 (en) 2009-12-01 2018-08-31 Translate Bio, Inc. Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases
EP4074693A1 (en) 2011-06-08 2022-10-19 Translate Bio, Inc. Cleavable lipids
KR20220025112A (ko) 2011-06-08 2022-03-03 샤이어 휴먼 지네틱 테라피즈 인크. Mrna 전달을 위한 지질 나노입자 조성물 및 방법
US9512073B2 (en) 2011-10-27 2016-12-06 Massachusetts Institute Of Technology Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
EA201492055A1 (ru) * 2012-06-08 2015-11-30 Шир Хьюман Дженетик Терапис, Инк. ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
EA201591229A1 (ru) 2013-03-14 2016-01-29 Шир Хьюман Дженетик Терапис, Инк. Способы очистки матричной рнк
EA201591283A1 (ru) 2013-03-14 2016-02-29 Шир Хьюман Дженетик Терапис, Инк. Количественная оценка эффективности кэп матричной рнк
ES3032935T3 (en) * 2013-10-22 2025-07-29 Translate Bio Inc Lipid formulations for delivery of messenger rna
EP4729528A3 (en) 2014-04-25 2026-06-24 Translate Bio, Inc. Methods for purification of messenger rna
AU2016251687C1 (en) * 2015-04-22 2023-07-27 CureVac SE RNA containing composition for treatment of tumor diseases
RS63625B1 (sr) * 2016-05-18 2022-10-31 Modernatx Inc Kombinacije irnk koje kodiraju imunomodulirajuće polipeptide i njihova upotreba
CA3042015A1 (en) * 2016-10-26 2018-05-03 Modernatx, Inc. Messenger ribonucleic acids for enhancing immune responses and methods of use thereof
MX2019009070A (es) * 2017-02-01 2019-10-30 Modernatx Inc Composiciones de arnm terapeuticas inmunomoduladoras que codifican peptidos de mutacion de oncogenes de activacion.
KR20240144261A (ko) 2017-02-28 2024-10-02 사노피 치료적 rna
AU2018270111B2 (en) 2017-05-18 2022-07-14 Modernatx, Inc. Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof
TW202003032A (zh) 2018-03-23 2020-01-16 美商科迪亞克生物科學公司 包含s t i n g 促效劑之胞外囊泡
JP7256824B2 (ja) 2018-04-25 2023-04-12 エスリス ゲーエムベーハー 粒子状製剤用の凍結保護剤
EP3880174A2 (en) 2018-11-12 2021-09-22 Translate Bio, Inc. Methods for inducing immune tolerance

Similar Documents

Publication Publication Date Title
JP7744687B2 (ja) CAR mRNA送達のための脂質ナノ粒子とその製剤
US12528855B2 (en) KRAS variant mRNA molecules
JP2025084968A5 (cg-RX-API-DMAC7.html)
Rietwyk et al. Next-generation lipids in RNA interference therapeutics
AU2004283464B2 (en) Method of administering cationic liposomes comprising an active drug
JP6077509B2 (ja) 改良されたアミノ脂質および核酸の送達方法
JP2022552009A (ja) 薬物送達のための脂質及び脂質ナノ粒子製剤
JP2022532213A5 (cg-RX-API-DMAC7.html)
US9827196B2 (en) Method of administering a cationic liposomal preparation
GB2600859A (en) Improved lipid nanoparticles for delivery of nucleic acids
JP2011507534A5 (cg-RX-API-DMAC7.html)
JP2017536092A5 (cg-RX-API-DMAC7.html)
JP2011529912A (ja) 核酸送達システム用のナノ粒子組成物
HRP20180696T1 (hr) ISPORUKA iRNK ZA POVEĆANJE EKSPRESIJE PROTEINA I ENZIMA U LJUDSKIM GENETSKIM BOLESTIMA
JP2024535766A5 (cg-RX-API-DMAC7.html)
KR20250111222A (ko) 신규 이온화 가능한 지질 및 이를 포함하는 지질나노입자
JP2020504138A5 (cg-RX-API-DMAC7.html)
RU2021119834A (ru) МОЛЕКУЛЫ мРНК ВАРИАНТОВ KRAS
US20250375502A1 (en) Combination of il-12 and ox40l for cancer immunotherapy
WO2025226959A1 (en) Ionizable lipids and lipid nanoparticles and uses thereof